September 22, 2026
MTTI
MTTI, or Molecular Targeting Technologies, received a $3.17 million grant from the National Cancer Institute for its drug development efforts.
- Round
- Grant
- Amount raised
- $3.2M
- Lead investor
- National Cancer Institute (NCI)
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- 51-200 employees
- Website
- mtti.edu
- View profile →
Source: FinSMEs